Design, synthesis, antiproliferative evaluation, and molecular docking study of new quinoxaline derivatives as apoptotic inducers and EGFR inhibitors
- 22 March 2021
- journal article
- research article
- Published by Elsevier BV in Journal of Molecular Structure
- Vol. 1236, 130317
- https://doi.org/10.1016/j.molstruc.2021.130317
Abstract
No abstract availableKeywords
This publication has 76 references indexed in Scilit:
- Synthesis and antitumor activity of novel 6-aryl and 6-alkylpyrazolo[3,4-d]pyrimidin-4-one derivativesEuropean Journal of Medicinal Chemistry, 2010
- In vitrocytotoxic and antioxidative activity ofCornus masandCotinus coggygriaNatural Product Research, 2009
- Synthesis of novel quinoxaline derivatives and its cytotoxic activitiesBioorganic & Medicinal Chemistry Letters, 2009
- The BCL-2 protein family: opposing activities that mediate cell deathNature Reviews Molecular Cell Biology, 2008
- Sulforhodamine B colorimetric assay for cytotoxicity screeningNature Protocols, 2006
- A Combination of Docking/Dynamics Simulations and Pharmacophoric Modeling To Discover New Dual c-Src/Abl Kinase InhibitorsJournal of Medicinal Chemistry, 2006
- Synthesis of Cyclopeptidic Analogues of Triostin A with Quinoxalines or Nucleobases as ChromophoresEuropean Journal of Organic Chemistry, 2004
- Discovery of a Potent, Non-peptide Bradykinin B1 Receptor AntagonistJournal of the American Chemical Society, 2003
- Regioselectivity in preparation of unsymmetrically substituted 3-aminoquinoxalin-2(1H )-onesJournal of the Chemical Society, Perkin Transactions 1, 1999
- Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell deathCell, 1993